MedTrace Logo

Task-Specific Self-Rehabilitation Training (TASSRET) Trial

NCT07208422 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-19

No results posted yet for this study

Summary

The goal of this pilot RCT is to evaluate the effectiveness of a Task-specific Self-rehabilitation Training (TASSRET) program and compare the effect of the two formats of the TASSRET (video vs manual) on functional ability (upper extremity fine and gross motor skills, upper extremity manual dexterity and speed, voluntary movement and basic mobility, gait velocity, balance) and health-related quality of life among Hausa-native stroke survivors.

The main questions it aims to answer are:

1. What is the immediate effect and durability of TASSRET on functional ability (upper extremity fine and gross motor skills, upper extremity manual dexterity and speed, voluntary movement and basic mobility, gait velocity, balance) and health-related quality of life among the Hausa-native stroke survivors?
2. Which of the self-rehabilitation formats (TASSRET-manual or TASSRET-video) is more effective (immediate and durable) at improving functional ability (upper extremity fine and gross motor skills, upper extremity manual dexterity and speed, voluntary movement and basic mobility, gait velocity, balance) and health-related quality of life among the Hausa-native stroke survivors?

Conditions

  • Stroke
  • Stroke Hemorrhagic
  • Stroke Ischemic
  • Hemiparesis After Stroke

Interventions

BEHAVIORAL

Video-based Task-specific Training

Video-based self-administered TST

BEHAVIORAL

Manual-based Task-specific Training

Manual-based self-administered TST

Sponsors & Collaborators

  • Bayero University Kano, Nigeria

    collaborator OTHER

  • National Assembly Clinic

    lead OTHER

Principal Investigators

  • Rabiu Ibrahim, MSc · National Assembly Clinic

  • Isa U Lawal, PhD · Bayero University Kano, Nigeria

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-07
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07208422 on ClinicalTrials.gov